loader
Please Wait
Applying Filters...

Athena Athena

X

List of All Manufacturers & Suppliers for 18116 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 AMCINONIDE (2)

filter

01 ASTELLAS (2)

filter

01 CREAM;TOPICAL (2)

filter

01 0.025% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)

02 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** (1)

filter

01 USA (2)

URL Supplier Web Content
CREAM;TOPICAL
0.025% **Federal Regis...
CYCLOCORT
USA
18116
1982-01-01
DISCN
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
CREAM;TOPICAL
0.1% **Federal Registe...
CYCLOCORT
USA
18116
1982-01-01
DISCN
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 18116

Looking for CTD TGA MCC DOSSIER APPLICATION 18116 2

19

Astellas Pharma, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is AMCINONIDE, with a corresponding application number 18116 and regulatory information .

proudly manufactured in the

approval since 1982-01-01

Astellas Pharma's CYCLOCORT CREAM;TOPICAL, medication with 0.025% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of AMCINONIDE.

18

Astellas Pharma, based in Japan, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is AMCINONIDE, with a corresponding application number 18116 and regulatory information .

proudly manufactured in the

approval since 1982-01-01

Astellas Pharma's CYCLOCORT CREAM;TOPICAL, medication with 0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** of AMCINONIDE.

Post Enquiry
POST ENQUIRY